Literature DB >> 7588611

Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.

P Steiner1, A Philipp, J Lukas, D Godden-Kent, M Pagano, S Mittnacht, J Bartek, M Eilers.   

Abstract

Activation of conditional alleles of Myc can induce proliferation in quiescent cells. We now report that induction of Myc in density-arrested fibroblasts triggers rapid hyperphosphorylation of the retinoblastoma protein and activation of both cyclin D1- and cyclin E-associated kinase activities in the absence of significant changes in the amounts of cyclin-cdk complexes. Kinase activation by Myc is blocked by inhibitors of transcription and requires intact DNA binding and heterodimerization domains of Myc. Activation of cyclin E-cdk2 kinase in serum-starved cells occurs in two steps. The first is induced by Myc and involves the release of a 120 kDa cyclin E-cdk2 complex from a 250 kDa inactive complex that is present in starved cells. This is necessary, but not sufficient, to generate full kinase activity, as cdc25 phosphatase activity is limiting in the absence of external growth factors. In vivo cdc25 activity can be supplied by the addition of growth factors. In vitro recombinant cdc25a strongly activates the 120 kDa, but only poorly activates the 250 kDa cyclin E-cdk2 complex. Our data show that two distinct signals, one of which is supplied by Myc, are necessary for consecutive steps during growth factor-induced formation of active cyclin E-cdk2 complexes in G(o)-arrested rodent fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588611      PMCID: PMC394579          DOI: 10.1002/j.1460-2075.1995.tb00163.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  82 in total

1.  Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.

Authors:  D E Ayer; L Kretzner; R N Eisenman
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

2.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Authors:  V Baldin; J Lukas; M J Marcote; M Pagano; G Draetta
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

3.  Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.

Authors:  P S Danielian; R White; S A Hoare; S E Fawell; M G Parker
Journal:  Mol Endocrinol       Date:  1993-02

4.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

5.  Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.

Authors:  B Sebastian; A Kakizuka; T Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 6.  The functions of Myc proteins.

Authors:  A Meichle; A Philipp; M Eilers
Journal:  Biochim Biophys Acta       Date:  1992-12-16

7.  Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.

Authors:  W Gu; K Cechova; V Tassi; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Differential modulation of cyclin gene expression by MYC.

Authors:  P Jansen-Dürr; A Meichle; P Steiner; M Pagano; K Finke; J Botz; J Wessbecher; G Draetta; M Eilers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.

Authors:  M Pagano; R Pepperkok; J Lukas; V Baldin; W Ansorge; J Bartek; G Draetta
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  63 in total

1.  Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC.

Authors:  S Kolli; A M Buchmann; J Williams; S Weitzman; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.

Authors:  D Müller; K Thieke; A Bürgin; A Dickmanns; M Eilers
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

4.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

5.  Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

6.  Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2.

Authors:  A J Capobianco; P Zagouras; C M Blaumueller; S Artavanis-Tsakonas; J M Bishop
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

7.  Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation.

Authors:  Josephine White; Elaine Stead; Renate Faast; Simon Conn; Peter Cartwright; Stephen Dalton
Journal:  Mol Biol Cell       Date:  2005-02-09       Impact factor: 4.138

8.  Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

Authors:  K Alevizopoulos; J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

9.  Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.

Authors:  Kamdeo K Pramanik; Abhay K Singh; Manzar Alam; Tanushree Kashyap; Prajna Mishra; Aditya K Panda; Ratan K Dey; Ajay Rana; Siddavaram Nagini; Rajakishore Mishra
Journal:  Tumour Biol       Date:  2016-09-30

10.  Myc down-regulation affects cyclin D1/cdk4 activity and induces apoptosis via Smac/Diablo pathway in an astrocytoma cell line.

Authors:  D Amendola; M De Salvo; R Marchese; C Verga Falzacappa; A Stigliano; E Carico; E Brunetti; M Moscarini; B Bucci
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.